Company intelligence / Profile preview

Prairie Plant Systems

Saskatoon, Saskatchewan, Canadanewswire.ca ↗

Ownership: Private
Development stage: Commercial

Overview

Prairie Plant Systems pioneered the use of underground and biosecure facilities to produce pharmaceutical-grade plants. It was the sole supplier of medical cannabis to Health Canada from about 2000–2013. Its work laid the foundation for CanniMed Therapeutics’ commercial and clinical programs before acquisition by Aurora Cannabis.

Therapeutic areas: OtherNeurology
Modalities: Plant-derived pharmaceuticals (notably medical cannabis)Micropropagation of fruit trees and medicinal plants
Industry: Biotech

Drug pipeline

1 asset

CanniMed

Unknown

Partnerships

Health Canada contract as exclusive supplier of medical cannabis from ~2000–2013Collaborations with National Research Council’s Plant Biotechnology Institute & Agriculture Canada

Beyond the preview

Go deeper on Prairie Plant Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prairie Plant Systems.

Explore the full profile